GB0610090D0 - Particulate drug compositions and their uses - Google Patents

Particulate drug compositions and their uses

Info

Publication number
GB0610090D0
GB0610090D0 GBGB0610090.3A GB0610090A GB0610090D0 GB 0610090 D0 GB0610090 D0 GB 0610090D0 GB 0610090 A GB0610090 A GB 0610090A GB 0610090 D0 GB0610090 D0 GB 0610090D0
Authority
GB
United Kingdom
Prior art keywords
drug compositions
particulate drug
particulate
compositions
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0610090.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GBGB0610090.3A priority Critical patent/GB0610090D0/en
Publication of GB0610090D0 publication Critical patent/GB0610090D0/en
Priority to PCT/GB2007/001873 priority patent/WO2007135409A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
GBGB0610090.3A 2006-05-20 2006-05-20 Particulate drug compositions and their uses Ceased GB0610090D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0610090.3A GB0610090D0 (en) 2006-05-20 2006-05-20 Particulate drug compositions and their uses
PCT/GB2007/001873 WO2007135409A1 (en) 2006-05-20 2007-05-18 Particulate drug and drug compositions and their uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0610090.3A GB0610090D0 (en) 2006-05-20 2006-05-20 Particulate drug compositions and their uses

Publications (1)

Publication Number Publication Date
GB0610090D0 true GB0610090D0 (en) 2006-06-28

Family

ID=36660578

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0610090.3A Ceased GB0610090D0 (en) 2006-05-20 2006-05-20 Particulate drug compositions and their uses

Country Status (2)

Country Link
GB (1) GB0610090D0 (en)
WO (1) WO2007135409A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2209769A1 (en) * 2007-10-25 2010-07-28 Merck Frosst Canada Ltd. Novel crystalline salts of montelukast
JP5936353B2 (en) 2008-07-18 2016-06-22 プロソニックス リミテッドＰｒｏｓｏｎｉｘ Ｌｉｍｉｔｅｄ Method for improving the crystallinity of fluticasone particles
CA2740360A1 (en) * 2008-10-14 2010-04-22 Activaero Gmbh Method for treatment of copd and other pulmonary diseases
CN102458684B (en) * 2009-05-11 2016-02-10 莫纳什大学 For the microfluidic device of the atomization of liquid
JOP20120023B1 (en) 2011-02-04 2022-03-14 Novartis Ag Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases
GB201113662D0 (en) 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
WO2014007772A2 (en) * 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
WO2014007771A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising muscarinic receptor antagonist
EP2950792A1 (en) 2013-01-31 2015-12-09 Prosonix Limited Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
FI20002216A0 (en) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Combination particles for asthma therapy
US20040197275A1 (en) * 2002-10-17 2004-10-07 Ecole Polytechnique Federale De Lausanne Process for the manufacture of powders of inhalable medicaments
JP5154078B2 (en) * 2003-02-21 2013-02-27 ザ ユニヴァーシティ オブ バース Particle manufacturing process
US8475845B2 (en) * 2005-07-15 2013-07-02 Map Pharmaceuticals, Inc. Method of particle formation

Also Published As

Publication number Publication date
WO2007135409A1 (en) 2007-11-29

Similar Documents

Publication Publication Date Title
IL242883B (en) Arylamino- and heteroarylamino-substituted dioxoazolines and pharmaceutical compositions comprising them
EP2056835A4 (en) Pharmaceutical compositions and uses thereof
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
IL190292A (en) Pyridopyrimidinone derivatives and pharmaceutical compositions comprising them
EP1857489A4 (en) Microparticle and pharmaceutical composition
IL194751A0 (en) Drugs and uses
EP1890677A4 (en) Pharmaceutical compositions and use thereof
ZA200810116B (en) Pharmaceutical composition comprising amlodipine and losartan
SI2154966T1 (en) Benzimidazoles and pharmaceutical compositions thereof
IL193211A (en) Indazole-heteroaryl derivatives and pharmaceutical compositions comprising them
HUS1800034I1 (en) Anti-fgf23 antibody and pharmaceutical composition comprising the same
IL197107A0 (en) Pharmaceutical compositions including vitamin d and corticosteriod
HUS2000053I1 (en) Quinolinone derivatives and their pharmaceutical compositions
GB0610090D0 (en) Particulate drug compositions and their uses
EP2070919A4 (en) Spiroquinone compound and pharmaceutical composition
GB0614365D0 (en) Pharmaceutical compositions and their use
EP2029132A4 (en) Anti-histamine compositions and use thereof
GB0611422D0 (en) Polymeric particles and their preparation
EP1998753A4 (en) High-deposition compositions and uses thereof
IL192824A (en) Peptidic compounds, pharmaceutical compositions comprising them and uses thereof
EP1937292A4 (en) Lopap-based pharmaceutical compositions and uses thereof
EP2114404A4 (en) Pharmaceutical compound and composition
EP2010141A4 (en) High-deposition compositions and uses thereof
GB0600336D0 (en) Composition and uses thereof
GB0701295D0 (en) Z-stilbenes derivatives and the pharmaceutical composition thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)